COMPARE · Data as of August 21, 2026
DOCS vs PRVA
Verdict: Side-by-side breakdown using the Bull Rankings model. DOCS scored 84.1, PRVA scored 56.3 — DOCS leads.
Compare another set
DOCS
Doximity, Inc.
84.1
$25.33 · $4.5B
fundamentals as of
Score gap
27.8
DOCS leads
PRVA
Privia Health Group, Inc.
56.3
$21.12 · $2.7B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestDOCS30.2x
- Fastest growthPRVA+24.1%
- Strongest balance sheetPRVA0.01
- Highest qualityDOCS89 / 100
- Largest discount to fair valuePRVA-14%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
DOCS
stronger →← stronger
PRVA
89
Qualityreturns · margins · balance sheet
45
85
Growthrevenue & earnings expansion
91
79
Valuevaluation vs sector peers
44
DOCS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
DOCS
PRVA
$306mC
FCF
$131mC
+11.2%B
Rev
+24.1%A-
0.01A-
D/E
0.01A
30.2xB
P/E
96.0xD
0.59A-
PEG
4.50D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
DOCS
PRVA
8% below
Price vs fair valuelower is cheaper
14% below
~7%/yr
Growth the price implies10-yr FCF · lower = less priced in
~9%/yr
-5%
1-yr DCF upside
-8%
+9%
5-yr DCF upside
+16%
+33%
10-yr DCF upside
+63%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
DOCS
Why this score
- Durable high returns
PRVA
Why this score
- Diluting shareholders
The companies
DOCSDoximity, Inc.
Why now
Health Information Services · market cap $4.5b. Down 67% from 52-week high of $76.51 — deep drawdown territory. Revenue growing +11%, comfortably above the S&P median. PEG 0.59 — paying under fair value for the growth rate. 18 sell-side analysts rate this a Hold with a mean 1-yr target of $29.39 (implying +16% upside).
Moat
Net margin 25% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 18% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 183% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 67% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 30x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
PRVAPrivia Health Group, Inc.
Why now
Health Information Services · market cap $2.7b. Down 27% from 52-week high of $28.82 — deep drawdown territory. Revenue growing +24%, comfortably above the S&P median. 18 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $31.67 (implying +50% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trailing P/E 96.0x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Net margin 1.2% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where DOCS and PRVA diverge
On the headline score the gap is 27.8 points in favor of DOCS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- QualityDOCS 88.6 · PRVA 44.6DOCS +44.0
- ValueDOCS 78.9 · PRVA 44.0DOCS +34.9
- GrowthDOCS 85.0 · PRVA 91.1PRVA +6.1
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.